Yakult Honsha Co Ltd
Company Profile
Business description
Yakult Honsha is a pioneer in probiotics, which launched the probiotic drinks Yakult in 1935 after Minoru Shirota’s discovery of Lactobacillus casei strain Shirota, a strain of lactic acid bacteria proved to be able to live in intestines, in 1930. It operates in 40 countries across four continents selling mainly the Yakult probiotic drinks. Apart from the retail outlets, the home delivery channel, served by a team of 83,000 Yakult Ladies globally, contributes about 45% of its probiotic drink volume. Overseas markets comprise 40% of group sales and profits. Yakult has built a meaningful presence in populated emerging markets including China, Indonesia, Mexico, and Brazil. It plans to step up expansion in the US. It also operates a pharmaceutical business with an emphasis on oncology drugs.
Contact
1-19 Higashi Shimbashi 1-chome
Minato-ku
Tokyo105-0021
JPNT: +81 335748960
Sector
Consumer Defensive
Stock type
Defensive
Industry
Beverages - Non-Alcoholic
Fiscal Year End
31 March 2025
Employees
29,627
Yakult Honsha Co Ltd News & Analysis
stocks
Japanese consumer stocks eyeing greener pastures abroad
stocks
Four Asian consumer defensive stocks defying the trade war
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,377.40 | 60.70 | 0.73% |
| CAC 40 | 7,274.48 | 19.89 | -0.27% |
| DAX 40 | 19,884.75 | 85.11 | -0.43% |
| Dow JONES (US) | 42,840.26 | 498.02 | 1.18% |
| FTSE 100 | 8,084.61 | 20.71 | -0.26% |
| HKSE | 19,720.70 | 31.81 | -0.16% |
| NASDAQ | 19,572.60 | 199.83 | 1.03% |
| Nikkei 225 | 39,040.72 | 338.82 | 0.88% |
| NZX 50 Index | 12,927.42 | 23.31 | 0.18% |
| S&P 500 | 5,930.85 | 63.77 | 1.09% |
| S&P/ASX 200 | 8,126.80 | 59.80 | 0.74% |
| SSE Composite Index | 3,368.07 | 1.96 | -0.06% |